rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2004-10-19
|
pubmed:abstractText |
Rapid-cycling (RC) bipolar disorder patients experience high levels of morbidity, typically respond unsatisfactorily to available treatments, and, so, require additional studies of novel treatments. We report on the first controlled study comparing acute and continuous clinical outcomes in RC and non-RC manic patients treated with olanzapine.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0160-6689
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1420-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15491248-Adult,
pubmed-meshheading:15491248-Antipsychotic Agents,
pubmed-meshheading:15491248-Benzodiazepines,
pubmed-meshheading:15491248-Bipolar Disorder,
pubmed-meshheading:15491248-Drug Screening Assays, Antitumor,
pubmed-meshheading:15491248-Drug Therapy, Combination,
pubmed-meshheading:15491248-Female,
pubmed-meshheading:15491248-Fluoxetine,
pubmed-meshheading:15491248-Humans,
pubmed-meshheading:15491248-Lithium,
pubmed-meshheading:15491248-Longitudinal Studies,
pubmed-meshheading:15491248-Male,
pubmed-meshheading:15491248-Meta-Analysis as Topic,
pubmed-meshheading:15491248-Proportional Hazards Models,
pubmed-meshheading:15491248-Psychiatric Status Rating Scales,
pubmed-meshheading:15491248-Survival Analysis,
pubmed-meshheading:15491248-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
|
pubmed:affiliation |
Bipolar Disorders Program, Department of Psychiatry, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain. evieta@clinic.ub.es
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|